medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2016, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2016; 14 (2)

Cutaneous manifestations of sepsis

Chang PO, Barrios CAB, Sánchez Y

Language: Spanish
References: 21
Page: 155-158
PDF size: 153.51 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Bone, R.C., Sibbald, W.J. y Sprung, C.L., “The accp-sccm consensus conference on sepsis and organ failure”, Chest, 1992, 101: 1481-1483.

  2. Dellinger, P., Levy, M., Rhodes, A. et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012”, Journal of Critical Care Medicine, 2013, 41 (2): 580-637.

  3. Kaukonen, K., Bailey, M., Pilcher, D. et al., Systemic inflammatory response syndrome criteria in defining severe sepsis”, N Engl J Med, 2015, 372: 1629-1638.

  4. Shankar-Hari et al., “Judging quality of current septic shock definitions and criteria”, Critical Care, 2015, 19: 445.

  5. Seymour, C.W. y Rosengart, M. R., “Septic shock. Advances in diagnosis and treatment”, jama, 2015, 314 (7): 708-717.

  6. Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J. y Pinsky, M.R., “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care”, Crit Care Med, 2001, 29: 1303-1310.

  7. Lagu, T., Rothberg, M.B., Shieh, M.S., Pekow, P.S., Steingrub, J.S. y Lindenauer, P.K., “Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007”, Crit Care Med, 2012, 40: 754-6. [Erratum, Crit Care Med, 2012, 40: 2932.]

  8. Adhikari, N.K., Fowler, R.A., Bhagwanjee, S. y Rubenfeld, G.D., “Critical care and the global burden of critical illness in adults”, Lancet, 2010, 376: 1339-1346.

  9. Martin, G.S., Mannino, D.M., Eaton, S. y Moss, M., “The epidemiology of sepsis in the United States from 1979 through 2000”, N Engl J Med, 2003, 348: 1546-1554.

  10. Vincent, J.L., Rello, J., Marshall, J. et al., “International study of the prevalence and outcomes of infection in intensive care units”, jama, 2009, 302: 2323-2329.

  11. Ranieri, V.M., Thompson, B.T., Barie, P.S. et al., “Drotrecogin alfa (activated) in adults with septic shock”, N Engl J Med, 2012, 366: 2055-2064.

  12. Opal, S.M., Garber, G.E., La Rosa, S.P. et al., “Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)”, Clin Infect Dis, 2003, 37: 50-58.

  13. Tomasini, C., “Septic vasculitis and vasculopathy in some infectious emergencies: the perspective of the histopathologist”, G Ital Dermatol Venereol, 2015, 150 (1): 73-85.

  14. Bone, R.C., “Gram-positive organisms and sepsis”, Arch Intern Med, 1994, 154: 26-34.

  15. Robboy, S., Martin, C., Colman, R. et al., “The skin in disseminated intravascular coagulation”, British Journal of Dermatology, 1973, 88: 221.

  16. Delgado-Jiménez, Y. et al., “Acute bacterial septic vasculopathy”, International Journal of Dermatology, 2013, 52: 1071-1080.

  17. Korb, L. e English, J., The skin in infective endocarditis, sepsis, septic shock, and disseminated intravascular coagulation, Fitzpatrick’s dermatology in general medicine, vol. 2, Nueva York, McGraw Hill, 2012, pp. 2197-2199.

  18. Briceño, I., “Sepsis: etiologia, clínica y diagnóstico”, Medicrit, 2005, 2 (9): 203-213.

  19. Lerolle, N., Carlotti, A. y Melican, K., “Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans”, J Respir Crit Care Med, 2013; 15, 188 (6): 684-692.

  20. Vera-Kellet, C., Del Puerto, C., Ruiz, F. et al., “Septic vasculitis caused by listeria monocytogenes”, Rev Chilena Infectol, 2014, 31 (6): 746-749.

  21. Chang, P. y Caballeros, C.R., “Manifestaciones cutáneas acrales de sepsis”, Dermatología Cosmética, Médica y Quirúrgica, 2012, 10 (2): 112-114.




2020     |     www.medigraphic.com